seed
Stage
1
Investors
About
PharmatrophiX is a clinical-stage biopharmaceutical company developing small-molecule therapies targeting neurotrophin receptors to prevent neurodegeneration and promote synaptic resilience in neurodegenerative diseases such as Alzheimer's.
Explore PharmatrophiX's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.